Logo image of CLH

CLEAN HARBORS INC (CLH) Stock Fundamental Analysis

NYSE:CLH - New York Stock Exchange, Inc. - US1844961078 - Common Stock - Currency: USD

234.15  +3.81 (+1.65%)

After market: 234.15 0 (0%)

Fundamental Rating

5

We assign a fundamental rating of 5 out of 10 to CLH. CLH was compared to 83 industry peers in the Commercial Services & Supplies industry. CLH has only an average score on both its financial health and profitability. While showing a medium growth rate, CLH is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

In the past year CLH was profitable.
CLH had a positive operating cash flow in the past year.
In the past 5 years CLH has always been profitable.
In the past 5 years CLH always reported a positive cash flow from operatings.
CLH Yearly Net Income VS EBIT VS OCF VS FCFCLH Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M

1.2 Ratios

CLH's Return On Assets of 5.40% is fine compared to the rest of the industry. CLH outperforms 67.47% of its industry peers.
The Return On Equity of CLH (15.21%) is better than 73.49% of its industry peers.
The Return On Invested Capital of CLH (7.88%) is better than 63.86% of its industry peers.
The Average Return On Invested Capital over the past 3 years for CLH is below the industry average of 11.67%.
Industry RankSector Rank
ROA 5.4%
ROE 15.21%
ROIC 7.88%
ROA(3y)6.03%
ROA(5y)4.99%
ROE(3y)17.95%
ROE(5y)15.47%
ROIC(3y)8.67%
ROIC(5y)7.33%
CLH Yearly ROA, ROE, ROICCLH Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 10 15 20

1.3 Margins

Looking at the Profit Margin, with a value of 6.58%, CLH is in the better half of the industry, outperforming 72.29% of the companies in the same industry.
CLH's Profit Margin has improved in the last couple of years.
CLH has a better Operating Margin (11.04%) than 74.70% of its industry peers.
CLH's Operating Margin has improved in the last couple of years.
CLH has a Gross Margin of 30.76%. This is comparable to the rest of the industry: CLH outperforms 49.40% of its industry peers.
In the last couple of years the Gross Margin of CLH has remained more or less at the same level.
Industry RankSector Rank
OM 11.04%
PM (TTM) 6.58%
GM 30.76%
OM growth 3Y7.87%
OM growth 5Y11.1%
PM growth 3Y8.55%
PM growth 5Y18.99%
GM growth 3Y-0.48%
GM growth 5Y0.63%
CLH Yearly Profit, Operating, Gross MarginsCLH Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20 30

5

2. Health

2.1 Basic Checks

CLH has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
Compared to 1 year ago, CLH has about the same amount of shares outstanding.
Compared to 5 years ago, CLH has less shares outstanding
Compared to 1 year ago, CLH has a worse debt to assets ratio.
CLH Yearly Shares OutstandingCLH Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M
CLH Yearly Total Debt VS Total AssetsCLH Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

2.2 Solvency

CLH has an Altman-Z score of 3.42. This indicates that CLH is financially healthy and has little risk of bankruptcy at the moment.
With a decent Altman-Z score value of 3.42, CLH is doing good in the industry, outperforming 68.67% of the companies in the same industry.
CLH has a debt to FCF ratio of 8.22. This is a slightly negative value and a sign of low solvency as CLH would need 8.22 years to pay back of all of its debts.
CLH has a Debt to FCF ratio of 8.22. This is in the better half of the industry: CLH outperforms 61.45% of its industry peers.
CLH has a Debt/Equity ratio of 1.08. This is a high value indicating a heavy dependency on external financing.
CLH has a Debt to Equity ratio of 1.08. This is in the lower half of the industry: CLH underperforms 67.47% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.08
Debt/FCF 8.22
Altman-Z 3.42
ROIC/WACC0.97
WACC8.15%
CLH Yearly LT Debt VS Equity VS FCFCLH Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B 2.5B

2.3 Liquidity

A Current Ratio of 2.37 indicates that CLH has no problem at all paying its short term obligations.
The Current ratio of CLH (2.37) is better than 78.31% of its industry peers.
CLH has a Quick Ratio of 1.98. This is a normal value and indicates that CLH is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 1.98, CLH is in the better half of the industry, outperforming 79.52% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.37
Quick Ratio 1.98
CLH Yearly Current Assets VS Current LiabilitesCLH Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B

5

3. Growth

3.1 Past

The Earnings Per Share has been growing slightly by 4.34% over the past year.
CLH shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 31.46% yearly.
CLH shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 8.52%.
Measured over the past years, CLH shows a quite strong growth in Revenue. The Revenue has been growing by 11.54% on average per year.
EPS 1Y (TTM)4.34%
EPS 3Y26.79%
EPS 5Y31.46%
EPS Q2Q%-15.5%
Revenue 1Y (TTM)8.52%
Revenue growth 3Y15.67%
Revenue growth 5Y11.54%
Sales Q2Q%4.01%

3.2 Future

Based on estimates for the next years, CLH will show a quite strong growth in Earnings Per Share. The EPS will grow by 12.30% on average per year.
Based on estimates for the next years, CLH will show a small growth in Revenue. The Revenue will grow by 5.21% on average per year.
EPS Next Y3.52%
EPS Next 2Y10.81%
EPS Next 3Y15.96%
EPS Next 5Y12.3%
Revenue Next Year4.15%
Revenue Next 2Y4.61%
Revenue Next 3Y5.35%
Revenue Next 5Y5.21%

3.3 Evolution

The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
CLH Yearly Revenue VS EstimatesCLH Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 2B 4B 6B 8B
CLH Yearly EPS VS EstimatesCLH Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 5 10

3

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 32.43, the valuation of CLH can be described as expensive.
Compared to the rest of the industry, the Price/Earnings ratio of CLH is on the same level as its industry peers.
When comparing the Price/Earnings ratio of CLH to the average of the S&P500 Index (27.45), we can say CLH is valued inline with the index average.
With a Price/Forward Earnings ratio of 25.70, CLH can be considered very expensive at the moment.
CLH's Price/Forward Earnings is on the same level as the industry average.
Compared to an average S&P500 Price/Forward Earnings ratio of 21.89, CLH is valued at the same level.
Industry RankSector Rank
PE 32.43
Fwd PE 25.7
CLH Price Earnings VS Forward Price EarningsCLH Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80

4.2 Price Multiples

CLH's Enterprise Value to EBITDA is on the same level as the industry average.
The rest of the industry has a similar Price/Free Cash Flow ratio as CLH.
Industry RankSector Rank
P/FCF 37.06
EV/EBITDA 13.62
CLH Per share dataCLH EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 20 40 60 80 100

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
The decent profitability rating of CLH may justify a higher PE ratio.
A more expensive valuation may be justified as CLH's earnings are expected to grow with 15.96% in the coming years.
PEG (NY)9.2
PEG (5Y)1.03
EPS Next 2Y10.81%
EPS Next 3Y15.96%

0

5. Dividend

5.1 Amount

CLH does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

CLEAN HARBORS INC

NYSE:CLH (7/3/2025, 7:12:54 PM)

After market: 234.15 0 (0%)

234.15

+3.81 (+1.65%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCommercial & Professional Services
GICS IndustryCommercial Services & Supplies
Earnings (Last)04-30 2025-04-30/bmo
Earnings (Next)07-30 2025-07-30/bmo
Inst Owners93.22%
Inst Owner Change-62.4%
Ins Owners5.57%
Ins Owner Change-0.87%
Market Cap12.55B
Analysts82.35
Price Target257.56 (10%)
Short Float %1.48%
Short Ratio2.22
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)7.06%
Min EPS beat(2)1.24%
Max EPS beat(2)12.88%
EPS beat(4)3
Avg EPS beat(4)4.91%
Min EPS beat(4)-3.86%
Max EPS beat(4)12.88%
EPS beat(8)6
Avg EPS beat(8)2.12%
EPS beat(12)10
Avg EPS beat(12)9.57%
EPS beat(16)14
Avg EPS beat(16)13.49%
Revenue beat(2)0
Avg Revenue beat(2)-1.31%
Min Revenue beat(2)-1.58%
Max Revenue beat(2)-1.03%
Revenue beat(4)2
Avg Revenue beat(4)-0.52%
Min Revenue beat(4)-1.58%
Max Revenue beat(4)0.5%
Revenue beat(8)3
Avg Revenue beat(8)-1.17%
Revenue beat(12)7
Avg Revenue beat(12)0.7%
Revenue beat(16)11
Avg Revenue beat(16)2.34%
PT rev (1m)0%
PT rev (3m)-4.2%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0.94%
EPS NY rev (1m)0%
EPS NY rev (3m)-0.12%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.31%
Revenue NY rev (1m)0.29%
Revenue NY rev (3m)-0.27%
Valuation
Industry RankSector Rank
PE 32.43
Fwd PE 25.7
P/S 2.11
P/FCF 37.06
P/OCF 16.49
P/B 4.88
P/tB 30.98
EV/EBITDA 13.62
EPS(TTM)7.22
EY3.08%
EPS(NY)9.11
Fwd EY3.89%
FCF(TTM)6.32
FCFY2.7%
OCF(TTM)14.2
OCFY6.06%
SpS110.96
BVpS47.99
TBVpS7.56
PEG (NY)9.2
PEG (5Y)1.03
Profitability
Industry RankSector Rank
ROA 5.4%
ROE 15.21%
ROCE 10.47%
ROIC 7.88%
ROICexc 8.7%
ROICexgc 14.08%
OM 11.04%
PM (TTM) 6.58%
GM 30.76%
FCFM 5.69%
ROA(3y)6.03%
ROA(5y)4.99%
ROE(3y)17.95%
ROE(5y)15.47%
ROIC(3y)8.67%
ROIC(5y)7.33%
ROICexc(3y)9.76%
ROICexc(5y)8.32%
ROICexgc(3y)16.3%
ROICexgc(5y)13.8%
ROCE(3y)11.52%
ROCE(5y)9.73%
ROICexcg growth 3Y10.92%
ROICexcg growth 5Y12.41%
ROICexc growth 3Y14.1%
ROICexc growth 5Y9.64%
OM growth 3Y7.87%
OM growth 5Y11.1%
PM growth 3Y8.55%
PM growth 5Y18.99%
GM growth 3Y-0.48%
GM growth 5Y0.63%
F-Score7
Asset Turnover0.82
Health
Industry RankSector Rank
Debt/Equity 1.08
Debt/FCF 8.22
Debt/EBITDA 2.58
Cap/Depr 101.08%
Cap/Sales 7.1%
Interest Coverage 4.14
Cash Conversion 70.83%
Profit Quality 86.54%
Current Ratio 2.37
Quick Ratio 1.98
Altman-Z 3.42
F-Score7
WACC8.15%
ROIC/WACC0.97
Cap/Depr(3y)108.74%
Cap/Depr(5y)95.27%
Cap/Sales(3y)7.36%
Cap/Sales(5y)6.97%
Profit Quality(3y)77.75%
Profit Quality(5y)110.67%
High Growth Momentum
Growth
EPS 1Y (TTM)4.34%
EPS 3Y26.79%
EPS 5Y31.46%
EPS Q2Q%-15.5%
EPS Next Y3.52%
EPS Next 2Y10.81%
EPS Next 3Y15.96%
EPS Next 5Y12.3%
Revenue 1Y (TTM)8.52%
Revenue growth 3Y15.67%
Revenue growth 5Y11.54%
Sales Q2Q%4.01%
Revenue Next Year4.15%
Revenue Next 2Y4.61%
Revenue Next 3Y5.35%
Revenue Next 5Y5.21%
EBIT growth 1Y6.39%
EBIT growth 3Y24.78%
EBIT growth 5Y23.92%
EBIT Next Year74.71%
EBIT Next 3Y27.96%
EBIT Next 5Y20.03%
FCF growth 1Y1.22%
FCF growth 3Y3.81%
FCF growth 5Y11.72%
OCF growth 1Y9.82%
OCF growth 3Y12.52%
OCF growth 5Y13.49%